✦ LIBER ✦

Phase I study of BMS-184476, a new taxane analog, given weekly in patients with advanced malignancies

✍ Scribed by Sessa, C.; Highley, M.; Pagani, O.; Plummer, R.; de Jong, J.; Smith, K.; Bogaerts, J.; Renard, J.; Winograd, B.; Gallant, G.

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Pharmacokinetics (PK) of BMS-184476, a n

✍ Calvert, A.H.; Sessa, C.; Hughes, A.; Jochim, U.; Calvert, P.; Ghielmini, M.; Re 📂 Article 📅 1999 🏛 Elsevier Science 🌐 English ⚖ 159 KB

Phase I and pharmacokinetic study of BMS

📂 Article 📅 2002 🏛 Elsevier Science 🌐 English ⚖ 124 KB

Spisulosine (ES-285) given as a weekly t

✍ P. Schöffski; H. Dumez; R. Ruijter; B. Miguel-Lillo; A. Soto-Matos; V. Alfaro; G 📂 Article 📅 2011 🏛 Springer 🌐 English ⚖ 285 KB

567 A phase I and pharmacokinetic study

✍ R. Plummer; D. Fyfe; P. Woll; B. Reynolds; M. Voi; O. Peeters; P. Hewitt; K. Fis 📂 Article 📅 2003 🏛 Elsevier Science 🌐 English ⚖ 332 KB

A phase I study of sirolimus and bevaciz

✍ E.E.W. Cohen; M.R. Sharma; L. Janisch; M. Llobrera; L. House; K. Wu; J. Ramirez; 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 193 KB

Phase I study of weekly (day 1 and 8) do

✍ Ramesh K. Ramanathan; Sakkaraiappan Ramalingam; Merrill J. Egorin; Chandra P. Be 📂 Article 📅 2004 🏛 Springer 🌐 English ⚖ 227 KB